Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and ...

The mRNA molecule eventually breaks down in the body. The Cleveland Clinic reports that the risks of mRNA vaccines include pain or swelling at the injection site, fever, fatigue, headaches, muscle ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

The Trump administration is terminating biodefense research funding for mRNA projects, raising concerns about the nation’s ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...

GAAP EPS loss widened to $(1.22) from $(1.10) year over year in Q2 2025 as R&D expenses rose 47.7% and G&A expenses climbed 48.8% compared to Q2 2024. VAX-31 vaccine program advanced with FDA expanded ...

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Kennedy Jr. pulled the plug Tuesday on half a billion dollars of vaccine research, POLITICO’s David Lim reports. The longtime ...

Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...